The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of mixed formulation aprepitant and palonosetron (QLM2010) for prevention of cisplatin-based highly emetogenic chemotherapy-induced nausea and vomiting: A multicenter, randomized, double-blind, double-dummy, positive-controlled phase III study.
 
Jieer Ying
No Relationships to Disclose
 
Qingshan Li
No Relationships to Disclose
 
Shuang Leng
No Relationships to Disclose
 
Na Li
No Relationships to Disclose
 
Chunling Liu
No Relationships to Disclose
 
Lin Lai
No Relationships to Disclose
 
Tienan Yi
No Relationships to Disclose
 
Kaijian Lei
No Relationships to Disclose
 
Xisheng Fang
No Relationships to Disclose
 
SongNan Zhang
No Relationships to Disclose
 
Hailong Wei
No Relationships to Disclose
 
Honglin Hu
No Relationships to Disclose
 
Qiong Wang
No Relationships to Disclose
 
Yanxia Zhang
No Relationships to Disclose
 
Xingli Gu
Employment - QiLu Pharmaceutical
 
Yue Wang
Employment - QiLu Pharmaceutical
 
Xiaojie Du
Employment - QiLu Pharmaceutical
 
Yuanyuan Li
Employment - QiLu Pharmaceutical
 
Xiangdong Cheng
No Relationships to Disclose